head1

 

Star InactiveStar InactiveStar InactiveStar InactiveStar Inactive

On July 28, the Wall Street Journal ran the article “Why Is the FDA Attacking a Safe, Effective Drug?” In it, it was outlined the potential value of the antiparasitic drug ivermectin for Covid-19, and the authors questioned the FDA’s vigorous attack on ivermectin.

Here is the authors' response.

Add a comment

Date
Clear filters